FACS FACOG - INVO Bioscience VP Integration
| INVO Stock | USD 0.92 0.01 1.08% |
Insider
FACS FACOG is VP Integration of INVO Bioscience
| Address | 5582 Broadcast Court, Sarasota, FL, United States, 34240 |
| Phone | 978 878 9505 |
| Web | https://www.invobio.com |
INVO Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.3385) % which means that it has lost $0.3385 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.6105) %, meaning that it created substantial loss on money invested by shareholders. INVO Bioscience's management efficiency ratios could be used to measure how well INVO Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of May 2024, Return On Tangible Assets is likely to drop to -0.77. In addition to that, Return On Capital Employed is likely to drop to -0.56. At this time, INVO Bioscience's Intangibles To Total Assets are very stable compared to the past year. As of the 5th of May 2024, Asset Turnover is likely to grow to 0.28, while Net Tangible Assets are likely to drop (1.2 M).Similar Executives
| Showing other executives | INSIDER Age | ||
| Philip Boudreau | Abbott Laboratories | 51 | |
| Andrea Wainer | Abbott Laboratories | 55 | |
| Gregory Ahlberg | Abbott Laboratories | 54 | |
| Charles Brynelsen | Abbott Laboratories | 63 | |
| Michael Dale | Abbott Laboratories | 61 | |
| Elaine Leavenworth | Abbott Laboratories | 65 | |
| Randel Woodgrift | Abbott Laboratories | 59 | |
| Lisa Earnhardt | Abbott Laboratories | 54 | |
| Michael Pederson | Abbott Laboratories | 59 | |
| Christopher Calamari | Abbott Laboratories | 50 | |
| Sammy Karam | Abbott Laboratories | 59 | |
| John Ginascol | Abbott Laboratories | 62 | |
| Mary Moreland | Abbott Laboratories | 58 | |
| Louis Morrone | Abbott Laboratories | 44 | |
| James Young | Abbott Laboratories | N/A | |
| Alejandro Wellisch | Abbott Laboratories | 49 | |
| Michael Roman | Abbott Laboratories | 61 | |
| Christopher Scoggins | Abbott Laboratories | 54 | |
Management Performance
| Return On Equity | -10.61 | ||||
| Return On Asset | -0.34 |
INVO Bioscience Leadership Team
Elected by the shareholders, the INVO Bioscience's board of directors comprises two types of representatives: INVO Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INVO. The board's role is to monitor INVO Bioscience's management team and ensure that shareholders' interests are well served. INVO Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INVO Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MD, Medical Director | ||
| FACS FACOG, VP Integration | ||
| Bojan Mitrovic, Director US | ||
| Lori MarzilliKahler, VP Operations | ||
| Michael Campbell, COO Development | ||
| Terah Krigsvold, Controller | ||
| Chris Myer, Sr Americas | ||
| Steven Shum, CEO Director | ||
| Andrea Goren, Chief Officer | ||
| Robert Bowdring, Treasurer Secretary |
INVO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INVO Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.61 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (2.66) % | ||||
| Operating Margin | (1.09) % | ||||
| Current Valuation | 16.99 M | ||||
| Shares Outstanding | 2.74 M | ||||
| Shares Owned By Insiders | 0.84 % | ||||
| Shares Owned By Institutions | 4.14 % | ||||
| Number Of Shares Shorted | 17.55 K | ||||
| Price To Book | 5.72 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INVO Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.13) | Revenue Per Share 1.929 | Quarterly Revenue Growth 3.968 | Return On Assets (0.34) | Return On Equity (10.61) |
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.